Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study

NCT03490201 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.

NCT NCT03490201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03490201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of Ventricular Tachycardia (LESS-VT) Study
Lead sponsor
Abbott Medical Devices
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2018
Completion date
April 11, 2024
Enrollment
592 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia